Table 1.
The demographic, gynecologic, and clinical characteristics of the study patients.
| Parameter | Whole cohort (N = 50) | RPOC following medical pregnancy termination (N = 26)a | RPOC following medical treatment of early pregnancy failure (N = 24)b | p value |
|---|---|---|---|---|
| Age (years) | 27.8 ± 7.7 | 23.5 ± 6.7 | 32.5 ± 5.6 | <0.01 |
| Gravidity | 2 (1–8) | 1 (1–8) | 2 (1–5) | 0.1 |
| Parity | 0 (0–6) | 0 (0–6) | 1 (0–4) | 0.07 |
| Past cesarean section | 8 (16.0) | 2 (7.7) | 6 (25.0) | 0.1 |
| Vaginal bleeding | 33 (66.0) | 17 (65.4) | 16 (66.7) | 0.6 |
| Clinical presentation | ||||
| Fever | 4 (8.0) | 3 (11.5) | 1 (4.2) | 0.3 |
| Asymptomatic | 13 (26.0) | 6 (23.1) | 7 (29.2) | 0.4 |
| Size of RPOC finding on hysteroscopy (cm) | 2.1 ± 0.1 | 2.1 ± 0.6 | 2.1 ± 0.9 | 0.8 |
Data is presented as mean ± standard deviation, median (range) or number (%).
a Retained products of conception (RPOC) diagnosed after medical treatment with mifepristone-misoprostol for first trimester pregnancy termination.
b RPOC diagnosed following treatment with misoprostol for early pregnancy failure (early missed abortion).